Protein–Peptide Affinity Selection Mass Spectrometry Reveals a CD1-Mediated Interaction Regulating HDAC6-Tubulin Activity
Abstract Protein–protein interactions remain challenging to interrogate experimentally, particularly for multidomain enzymes that rely on cooperative and transient contacts. Here, we present a protein–peptide affinity selection mass spectrometry platform designed to identify peptide-level interaction sites between protein binding partners. Using histone deacetylase 6 and tubulin dimers as a proof-of-concept system, this approach enabled bidirectional mapping of interaction interfaces and identified previously unrecognized contacts that contribute to complex formation. A catalytic domain 1-derived histone deacetylase 6 peptide disrupted histone deacetylase 6-tubulin dimer binding and inhibited α-tubulin deacetylation in orthogonal binding and enzymatic assays, supporting a model in which catalytic domain 1 provides a stabilizing interaction contributing to productive catalysis. This proof-of-concept study supports the potential of protein–peptide affinity selection mass spectrometry as a strategy for dissecting protein–protein interaction interfaces and suggests that structural disruption of enzyme–substrate complexes may provide an alternative route to functional inhibition without direct active-site targeting.
Authors
- Ryan Kilburn (ORCID: https://orcid.org/0000-0002-4549-4679)
- Paresh C. Sanghani (ORCID: https://orcid.org/0009-0006-9157-1811)
- Michael J. Chalmers (ORCID: https://orcid.org/0000-0002-2139-6089)
- Jesus A. Gutierrez
- Sanchaita Das
- Caitlyn Keck
Institutions
- Eli Lilly (United States) (US)
Publication Details
- Journal
- ACS Omega
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1021/acsomega.6c06674
- Primary Topic
- Advanced Proteomics Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company